Asset Publisher

« Back

Azista

 

 

Construction of Pharmaceutical Plant by Azista Bhutan Healthcare Limited.

 

(A Joint Venture Company of Azista Industries Pvt. Ltd & Druk Holding and Investments Ltd.)
 
The groundbreaking ceremony (Salang Tendrel) for the construction of Pharmaceutical plant at Motanga Industrial Park held at 9:30 am on 10 th May 2018.
 
As the investment arm of the Royal Government of Bhutan, Druk Holding and Investments (DHI) has been exploring investments in various business sectors, which has immense contribution towards the socio-economic development of our country. One such initiative is Azista Bhutan Healthcare Limited (ABHL) (a joint venture company of Azista Industries Pvt. Ltd., India and Druk Holding and Investments Ltd.). ABHL will be setting up a full - fledged pharmaceutical plant at Motanga Industrial Park, Samdrupjongkhar to manufacture, package and distribute wide range of prescription medicines under the brand Azista Bhutan. Such facility would be first of its kind in Bhutan that would manufacture, package and distribute allopathic drugs.
 
Given the rising demand for pharmaceutical products both in the local and international markets, and the fact that Bhutan has been importing all allopathic drugs from outside, DHI took such initiative not only to curb import but also to promote brand Bhutan in a global market through export of locally manufactured quality pharmaceutical products. Once operational, the company would be manufacturing, packaging and distributing 99 types of products under 17 major therapies. Besides meeting domestic demand for pharmaceutical products, the plant will export to India and abroad. 
 
This project is expected to bring in lot of benefits to the economy in terms of foreign currency earnings from export, import of know-how, and most importantly, providing
employment opportunity. The company is projected to employ 190 people in various occupational fields. In addition, local skill development for manufacturing pharmaceutical
products would remain a top priority of this project. ABHL will eventually set up its own Research and Development (R&D) unit to improve quality of products and introduce new range of products in Bhutan and overseas market. This R&D initiative is expected to bring about much needed culture of innovation in Bhutan to meet social and commercial interest.
 
Pharmaceutical as a clean industry is known for not generating any toxic and hazardous effluents. The state of the art technology that would be deployed for this project will ensure that the plant does not emit hazardous materials into the atmosphere. ABHL is a project that is in compliance with the country's development philosophy of Gross National Happiness.
 
The construction of the plant will start once the monsoon season is over and is expected to complete in the second quarter of 2019.
 
[For any queries related to this project, you may please contact Mr. Sherab Namgay, Associate Director, Department of Investment, DHI. Mobile 17117485]